The Health-Related Quality of Life for Patients with Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS).
Myalgic encephalomyelitis (ME)/chronic fatigue syndrome (CFS) is a common, severe condition affecting 0.2 to 0.4 per cent of the population. Even so, no recent international EQ-5D based health-related quality of life (HRQoL) estimates exist for ME/CFS patients. The main purpose of this study was to...
Main Authors: | Michael Falk Hvidberg, Louise Schouborg Brinth, Anne V Olesen, Karin D Petersen, Lars Ehlers |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4492975?pdf=render |
Similar Items
-
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): An Overview
by: Undine-Sophie Deumer, et al.
Published: (2021-10-01) -
The Gut Microbiome in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS)
by: Rahel S. König, et al.
Published: (2022-01-01) -
How Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Progresses: The Natural History of ME/CFS
by: Luis Nacul, et al.
Published: (2020-08-01) -
Erratum: The Gut Microbiome in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS)
by: Frontiers Production Office
Published: (2022-03-01) -
Cellular Immune Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
by: Jacqueline M. Cliff, et al.
Published: (2019-04-01)